Tim Meyer, MD, PhD UCL Cancer Institute, University College London
- Status: Completed
- Year(s): 2015
- Research Type: Translational
- Primary Tumor Site: Other
- Area of Inquiry: Immune environment
The status of the immune ‘landscape’ of neuroendocrine tumors before therapy and after modulation by therapy is unknown. The proposed study will analyze reactive T cell subsets including characterization of the regulatory factors limiting effective immune-mediated tumor elimination. This will inform the development of a truly personalized medicine approach capable of inducing tumor regression and durable disease control.
- City: London
- State: International
- Grant Duration: 1 years
- Awards: No information
NETRF funds laboratory research to understand the development of neuroendocrine tumors and translational research to explore new concepts in treatment. Research grant descriptions and research updates from NETRF are not intended to serve as medical advice. It can take years for research discoveries to be fully validated and approved for patient care. Always consult your health care providers about your treatment options.